Detect
Identify high-value intersections among emerging science, unmet needs, behavior, technology, and cultural change.
Global Venture Builder
We build the companies the market cannot see yet.
Global Venture Builder discovers valuable opportunities hidden at the intersection of science, human behavior, capital, and cultural change—and transforms them into companies built to endure.
Our current development priority is W Benefits , an oral-care-first consumer-health company.
Work underwayW Benefits in development · Two explorations
Founding-team experience · Roles & context ↘
ALOHAP&G VenturesRitualRedesign HealthToriiThe Ark Wellness
The insight opens the door.Evidence earns the future.
01 / THESIS
The most valuable opportunities often appear before the market has language for them.
Major opportunities rarely arrive as polished business plans. They emerge as disconnected signals: a scientific development, an overlooked human behavior, a cultural shift, a technical capability, or an unmet need hidden inside an ordinary routine.
Most organizations recognize opportunities only after a category exists. GVB is designed to see earlier—and determine whether the signal deserves to become a company.
02 / THE PLATFORM
Insight is abundant.
Coordinated execution is rare.
GVB brings the capabilities normally distributed across separate organizations into one coordinated platform.
The objective is not to manufacture startups. It is to build ventures with enough evidence, coherence, and structural advantage to endure.
03 / THE METHOD
Every idea must earn the right to become a company.
Insight opens the door. Evidence earns the future. Progress is measured by the next meaningful risk removed—not by inflated certainty.
Interrogate
Challenge the thesis. Determine what must be scientifically, technically, commercially, and legally true.
De-risk
Advance feasibility, IP, regulatory strategy, clinical evidence, manufacturing, and market validation.
Construct
Unify product, company, brand, team, strategic relationships, and capital architecture.
Endure
Build systems capable of surviving beyond novelty, personalities, and market hype.
04 / CURRENT DIRECTIONS
One platform.
One development priority.
W Benefits is our current development priority. Women’s microbiome health and mineral delivery remain earlier-stage explorations—not launched businesses.
W Benefits
An oral-care-first consumer-health company developing one functional-floss program: a familiar cleaning ritual explored as a delivery opportunity. Daytime mints and evening melts remain companion concepts.
Roll prototypes are a development format, not a final launch decision. Formulation, performance, claims, and availability remain subject to validation.More from a familiar ritual. Still to be proven.Visit W Benefits ↗Women’s microbiome health
An emerging platform investigating products and delivery systems designed around the complexity, continuity, and frequently underserved realities of women’s microbiome health.
Opportunity definition · Evidence requirements · Product architecture · Clinical relevance · Defensible paths to marketDesigned around lived biology.Next-generation mineral delivery
An exploration of more effective and intelligent ways to deliver essential minerals and integrate them into daily life.
Bioavailability · Formulation · Safety · Toxicology · Intellectual property · Practical integrationEssential, delivered intelligently.Select a sphere for details · All summaries are available below
Development snapshot
What is being advanced now.
Work underway and next evidence gates. These are development directions, not completed milestones or launch announcements.
01
Current priority · Pre-launch
W Benefits
An oral-care-first consumer-health company developing one functional-floss program: a familiar cleaning ritual explored as a delivery opportunity. Daytime mints and evening melts remain companion concepts.
Visit W Benefits ↗Work underway
Unified floss formulation · coating, loading and release · manufacturing review
Roll prototypes are a development format, not a final launch decision. Formulation, performance, claims, and availability remain subject to validation.
Next evidence gate
Establish stability, compatibility, safety, performance and support for any finished-product claims.
02
Earlier-stage exploration
Women’s microbiome health
An emerging platform investigating products and delivery systems designed around the complexity, continuity, and frequently underserved realities of women’s microbiome health.
Exploration focus
Opportunity definition · evidence map · product architecture
Opportunity definition · Evidence requirements · Product architecture · Clinical relevance · Defensible paths to market
Next evidence gate
Clinical relevance and defensible path to market
03
Earlier-stage exploration
Next-generation mineral delivery
An exploration of more effective and intelligent ways to deliver essential minerals and integrate them into daily life.
Exploration focus
Delivery thesis · feasibility · intellectual-property review
Bioavailability · Formulation · Safety · Toxicology · Intellectual property · Practical integration
Next evidence gate
Safety, toxicology, and practical integration
05 / WHY THIS MATTERS
Too many consequential ideas die between discovery and execution.
The opportunity is rarely missing. The connective infrastructure is.
Scientists may understand the mechanism but lack company-building infrastructure.
Entrepreneurs may understand demand but lack scientific and regulatory depth.
Corporations may possess distribution but cannot always pursue opportunities outside existing categories.
Capital often arrives only after the hardest uncertainties have been resolved.
DISCOVERYGVBADOPTION
We build the connective tissue between discovery and adoption.
06 / CORE TEAM & STRATEGIC COLLABORATORS
Built by people who move between worlds.
Combining scientific curiosity, consumer understanding, creative intelligence, relationships, and disciplined venture construction.
Founder & CEO
Noah William Berman
Consumer-health innovation, venture creation, formulation, strategic pattern recognition, and navigating emerging products across commercial and institutional environments.
LinkedIn ↗
Co-Founder & Chief Creative Officer
Michael Grytsenko
Human behavior, cultural intelligence, venture narrative, brand architecture, creative direction, and translating complex ideas into experiences people can understand, desire, and support.
Michael’s profile ↗
Capital Strategy & International Partnerships
Hamed Salah
Venture builder and investment strategist supporting capital formation, investor diligence, financial architecture, and international partnerships across GVB’s development work.
Strategic Partnerships & Science Communication
Stacey Sude
A systems thinker and science storyteller working across integrative health, natural products, cultural intelligence, and partnership development.
Consumer Growth & Commercialization
Matt O’Connell
Consumer-health operator with experience scaling ALOHA and OWYN into national retail distribution. Founder and CEO of Day/Dream, bringing expertise across sales, product strategy, formulation, and commercialization.
Scientific Development & Formulation
Dr. Luke Bucci, PhD
Nutritional scientist and product-development leader with more than three decades of experience in supplements, formulation, regulatory strategy, product safety, and human health. Former VP of R&D at Ritual.
07 / BUILD WITH US
Bring the next useful step.
Start with W Benefits, strengthen the wider platform, or bring a capability that can move a specific development question forward.
Venture investors
Discuss W Benefits, its development priorities, open risks, and financing context.
Discuss W Benefits ↗Platform partners
Explore a strategic relationship across company building, infrastructure, or commercialization.
Propose a partnership ↗Bring a critical capability
For scientists, institutions, manufacturers, operators, and distributors who can materially accelerate a venture.
Introduce your capability ↗EXPERIENCE / WITH CONTEXT
Prior work, not a portfolio.
These names reflect the founding team’s prior experience—specifically Noah Berman’s roles and ecosystem exposure described below. They are not GVB portfolio investments, current clients, or endorsements.
A concrete example: Noah’s work at ALOHA included product development and formulation— practical consumer-health experience that informs the questions he brings to W Benefits today.
Read Noah’s experience profile ↗Noah / Prior experience
ALOHAProduct development & formulationP&G VenturesVenture ecosystem exposureRitualConsulting & product innovationRedesign HealthVenture-building ecosystemToriiConsulting & product innovationThe Ark WellnessFounder
Noah / Public-stage participation
Horasis GlobalNEXUS GlobalTransformative Family Office SummitNeuroscience20 / N20Society for Brain Mapping & TherapeuticsBrain Mapping Day at the U.S. CongressRA MA